Brief: Forward Pharma Announces Rescheduling Of The Ep2801355 Appeal Hearing To Sept. 6
Jan 12 (Reuters) - Forward Pharma A/S FWP.O :
* FORWARD PHARMA ANNOUNCES RESCHEDULING OF THE EP2801355
APPEAL
HEARING TO SEPTEMBER 6, 2021 DUE TO COVID-19 RESTRICTIONS
Source text for Eikon: ID:nGNX3yy4mq
Further company coverage: FWP.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Forward Pharma A/S
See all newsBrief: Forward Pharma- Announces Termination Of Its American Depositary Receipts Facility
U.S. STOCKS ON THE MOVE-Madrigal, Disney, Forward Pharma
Forward Pharma slides to record low on delisting notice from Nasdaq
Brief: Forward Pharma Announces Delisting Its American Depositary Shares From Nasdaq Capital Market
Brief: Forward Pharma A/S Submitted A Request For A Written Decision Regarding Petition For Review Regarding EP2801355 To The EBA